By Dr Chris Jolly

Conference Papers

Pimanda J; Hampton H; Boon P; Jolly C; Joshi S; Nguyen M; Koch F; Vafaee F; Polizzotto M; Swarbrick A; Thoms J; Zanini F, 2025, 'LONGITUDINAL SINGLE-CELL PROFILING OF MDS STEM/PROGENITOR CELLS REVEALS FEATURES OF AZACITIDINE RESPONSE AND RESISTANCE', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC

Neely A; Jolly C; Bray M; Carrasco R, 2024, 'Role of Diet in Management of Juvenile Idiopathic Arthritis: A Case Series', in OBESITY, WILEY, TX, San Antonio, pp. 92 - 92, presented at 42nd Annual Meeting of the Obesity-Society, TX, San Antonio, 03 November 2024 - 06 November 2024

Neely A; Bray M; Jolly C, 2023, 'Effects of ß-Hydroxybutyrate on CD4+T Cell Polarization and Function', in OBESITY, WILEY, TX, Dallas, pp. 258 - 258, presented at 41ST ANNUAL MEETING OF THE OBESITY-SOCIETY AT OBESITY WEEK, TX, Dallas, 14 October 2023 - 17 October 2023

Pham T; Lee G; Quach D; Galvan G; Jolly C; Cavazos D; Brenner A; deGraffenried L, 2016, 'Modulation of FASN under obese conditions', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, TX, San Antonio, presented at San Antonio Breast Cancer Symposium, TX, San Antonio, 06 December 2016 - 10 December 2016, http://dx.doi.org/10.1158/1538-7445.SABCS16-P6-02-05

Quach D; Lengfelder L; Winnika L; Harlow B; Galvan G; Jolly C; Brenner A; deGraffenried L, 2016, 'The importance of the ultimate ratio of Omega-6 to Omega-3 fatty acids in the efficacy of fish oil supplements in suppressing inflammation in obese postmenopausal women', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, TX, San Antonio, presented at San Antonio Breast Cancer Symposium, TX, San Antonio, 06 December 2016 - 10 December 2016, http://dx.doi.org/10.1158/1538-7445.SABCS16-P6-17-03

Thientosapol E; Boznjak D; Durack T; Stevanovski I; Jolly C, 2016, 'G1-phase nucleotide paucity causes AID-induced mismatch repair to be mutagenic in germinal centre B cells', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 1072 - 1072, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016

De Angulo A; Faris R; Jolly C; deGraffenried L, 2014, 'IL-17 as a novel molecular target for prostate cancer prevention', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SPAIN, European Org Res & Treatment Canc, Barcelona, pp. 49 - 49, presented at 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, SPAIN, European Org Res & Treatment Canc, Barcelona, 18 November 2014 - 21 November 2014, http://dx.doi.org/10.1016/S0959-8049(14)70268-0

Jolly C; Sharbeen G; Yee C; Smith A, 2012, 'Processing of AID-induced uracils in distinct cell cycle phases', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, MA, Boston, presented at 99th Annual Meeting of the American-Association-of-Immunologists, MA, Boston, 04 May 2012 - 08 May 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000304659700662&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Alejandra DA; Faris R; Cavazos D; deGraffenried L; Jolly C, 2012, 'Modulation of pro-inflammatory signaling pathways by aging T-lymphocytes contributes to a more malignant phenotype in prostate epithelial cells', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/1538-7445.AM2012-3553

Szerman E; Clergeau A; Jolly C; Joubert M; Reznik Y, 2010, 'Place of ART in the treatment of male infertility in patients with hypogonadotropic hypogonadism (HH): about 14 cases', in INTERNATIONAL JOURNAL OF ANDROLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. 87 - 87

Sale JE; Bemark M; Williams GT; Jolly CJ; Ehrenstein MR; Rada C; Milstein C; Neuberger MS, 2001, 'In vivo and in vitro studies of immunoglobulin gene somatic hypermutation', in Philosophical Transactions of the Royal Society B Biological Sciences, pp. 21 - 28

Jolly C; Kohonen-Corish M; Hodgkin P; Deenick E, 2000, 'MSH2-deficiency reduces the rate of switching to all mouse isotypes without altering the regulation of switching by cell division number', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A1046 - A1046, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000086643100792&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bauer G; Rice CR; Valdez P; Jolly CJ; Sauter S; Ibanez C; Sorenson J; ODea J; delaVega D; Kohn DB, 1997, 'Increased gene transfer into CD34+ cells using retroviral vectors produced by a canine packaging cell line.', in BLOOD, W B SAUNDERS CO, pp. 511 - 511

BARNICOT NA; HUEHNS ER; JOLLY CJ, 1968, 'STUDIES ON HAEMOGLOBIN VARIANTS OF IRUS MACAQUE', in HUMAN BIOLOGY, WAYNE STATE UNIV PRESS, pp. 119 - &

JOLLY CJ; BARNICOT NA, 1964, 'BIOCHEMICAL VARIATION IN MONKEYS', in HUMAN BIOLOGY, WAYNE STATE UNIV PRESS, pp. 72 - &

Conference Abstracts

Truong P; Shen S; Joshi S; Afrasiabi A; Zhong L; Raftery MJ; Larsson J; Lock RB; Walkley CR; Rokny HA; Thoms JAI; Jolly CJ; Pimanda JE, 2022, 'Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and Sumoylation Blockade in Myelodysplastic Syndromes and Acute Myeloid Leukemia', in Blood, American Society of Hematology, Vol. 140, pp. 220 - 221, http://dx.doi.org/10.1182/blood-2022-165713

Preprints

Thoms JAI; Hampton HR; Boon PLS; Stonehouse O; Zou X; Chung HM; Koch FC; Yan F; Joshi S; Nguyen MNT; Hung D; Wright DC; Vafaee F; Polizzotto MN; Swarbrick A; Huang Y; Jolly CJ; Zanini F; Pimanda JE, 2026, Single cell multiomics reveal clonal and functional dynamics of MDS stem/progenitor cells during hypomethylating therapy, http://dx.doi.org/10.64898/2026.03.13.711488

Schnegg-Kaufmann A; Thoms J; Bhuyan GS; Hampton H; Vaughan L; Rutherford K; Kakadia P; Johansson E; Failes T; Arndt G; Koval J; Lindeman R; Warburton P; Rodriguez-Meira A; Mead A; Unnikrishnan A; Bohlander S; Papaemmanuil E; Faridani O; Jolly C; Zanini F; Pimanda J, 2022, Single cell genotyping of matched bone marrow and peripheral blood cells in treatment naive and AZA-treated MDS and CMML, http://dx.doi.org/10.1101/2022.01.20.476890

Jolly C; Lee Q; Padula M; Pinello N; Williams S; O’Rourke M; Fumagalli MJ; Orkin J; Shaban B; Brenner O; Weninger W; de Souza WM; Melin A; Wong JJ-L; Crim M; Monette S; Roediger B, 2019, MKPV (aka MuCPV) and related chapparvoviruses are nephro-tropic and encode novel accessory proteins p15 and NS2, http://dx.doi.org/10.1101/732537

Jolly C; Gall M; Gorrell M; Cook A; Roediger B; Zhang HE; McCaughan G, 2018, Immune regeneration in irradiated mice is not impaired by the absence of DPP9 enzymatic activity [forthcoming publication], http://dx.doi.org/10.1101/431775

Hampton HR; Pan A; Carnell M; Wang B; Shinko D; Kasherman M; Slapetova I; Joshi S; Nguyen MNT; Yan F; Davidson S; Choi NFY; Wong JWH; Tedla N; Hiwase DK; Tobiasson M; Polizzotto MN; McGuire HM; Abbas HA; Javed A; Olivier J; Thoms JAI; Jolly CJ; Pimanda JE, Azacitidine Response in Myelodysplastic Syndromes is Marked by NK-like CD8 T-Cell Expansion and CXCL12+ Reticular Cell Remodeling, http://dx.doi.org/10.64898/2026.07.07.736922

Bhuyan GS; Yan F; Nguyen MNT; Chung HM; Zou X; Gullapalli V; Vaughan L; Stonehouse O; Hampton HR; Shen S; Truong P; Dissanayake R; Ghodousi ES; Joshi S; Koch FC; Zanini F; Vafaee F; Huang Y; Thoms JAI; Faridani OR; Jolly CJ; Pimanda JE, Cell-state-specific mechanisms of 5-azacytidine response in myelodysplastic neoplasms, http://dx.doi.org/10.64898/2026.04.26.720516

Michel A; Donovan T; Roediger B; Lee Q; Jolly C; Monette S, Chaphamaparvovirus Antigen and Nucleic Acids are not Detected in Kidney Tissues from Cats with Chronic Renal Disease or Immunosuppressive Diseases, http://dx.doi.org/10.1101/2021.03.30.437777

Thoms JAI; Yan F; Hampton HR; Davidson S; Joshi S; Saw J; Sarowar CH; Lim XY; Nunez AC; Kakadia PM; Bhuyan GS; Zou X; Nguyen M; Ghodousi ES; Koch FC; Vafaee F; Pickford R; Raftery MJ; Hough S; Buckland G; Bailey M; Ghodke Y; Absar N; Vaughan L; Pasalic L; Fong CY; Kenealy M; Hiwase DK; Stoddart RI; Mohammed S; Lee L; Passam FH; Larsen SR; Spring KJ; Skarratt KK; Rebeiro P; Presgrave P; Stevenson WS; Ling S; Tiley C; Fuller SJ; Roncolato F; Enjeti AK; Hoenemann D; Lemech C; Jolly CJ; Bohlander SK; Curtis DJ; Wong JWH; Unnikrishnan A; Hertzberg M; Olivier J; Polizzotto MN; Pimanda JE, Clinical Response to Azacitidine in Myelodysplastic Neoplasms is Associated with Distinct DNA Methylation Changes in Haematopoietic Stem and Progenitor cells in vivo, http://dx.doi.org/10.1101/2024.07.19.24310679

Truong P; Shen S; Joshi S; Islam I; Zhong L; Raftery MJ; Afrasiabi A; Alinejad-Rokny H; Nguyen M; Zou X; Bhuyan GS; Sarowar CH; Ghodousi ES; Stonehouse O; Mohamed S; Toscan CE; Connerty P; Kakadia PM; Bohlander SK; Michie KA; Larsson J; Lock RB; Walkley CR; Thoms JAI; Jolly CJ; Pimanda JE, Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and SUMOylation Blockade in MDS/AML, http://dx.doi.org/10.1101/2024.04.17.589858

Back to profile page